Validating the OCS‐Plus against a clinical standard: A brief report

This research aimed to determine the sensitivity and clinical validity of the OCS‐Plus, a stroke‐specific tablet‐based cognitive screening tool, in comparison with the MoCA, a routinely used screening tool, after stroke. Eighty‐six patients were recruited from Oxfordshire stroke wards over a 22‐mont...

Full description

Bibliographic Details
Main Authors: Roberts, R, Vohora, R, Webb, SS, Demeyere, N
Format: Journal article
Language:English
Published: Wiley 2024
_version_ 1811140066634891264
author Roberts, R
Vohora, R
Webb, SS
Demeyere, N
author_facet Roberts, R
Vohora, R
Webb, SS
Demeyere, N
author_sort Roberts, R
collection OXFORD
description This research aimed to determine the sensitivity and clinical validity of the OCS‐Plus, a stroke‐specific tablet‐based cognitive screening tool, in comparison with the MoCA, a routinely used screening tool, after stroke. Eighty‐six patients were recruited from Oxfordshire stroke wards over a 22‐month period and completed both screens. Overall, we found that the OCS‐Plus has good convergent validity and excellent sensitivity when compared with the MoCA. The OCS‐Plus is therefore of potential benefit to those seeking a sensitive screening tool.
first_indexed 2024-09-25T04:16:04Z
format Journal article
id oxford-uuid:c9b461f3-f986-4857-8dba-9c57638ced8d
institution University of Oxford
language English
last_indexed 2024-09-25T04:16:04Z
publishDate 2024
publisher Wiley
record_format dspace
spelling oxford-uuid:c9b461f3-f986-4857-8dba-9c57638ced8d2024-07-20T14:42:12ZValidating the OCS‐Plus against a clinical standard: A brief reportJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:c9b461f3-f986-4857-8dba-9c57638ced8dEnglishJisc Publications RouterWiley2024Roberts, RVohora, RWebb, SSDemeyere, NThis research aimed to determine the sensitivity and clinical validity of the OCS‐Plus, a stroke‐specific tablet‐based cognitive screening tool, in comparison with the MoCA, a routinely used screening tool, after stroke. Eighty‐six patients were recruited from Oxfordshire stroke wards over a 22‐month period and completed both screens. Overall, we found that the OCS‐Plus has good convergent validity and excellent sensitivity when compared with the MoCA. The OCS‐Plus is therefore of potential benefit to those seeking a sensitive screening tool.
spellingShingle Roberts, R
Vohora, R
Webb, SS
Demeyere, N
Validating the OCS‐Plus against a clinical standard: A brief report
title Validating the OCS‐Plus against a clinical standard: A brief report
title_full Validating the OCS‐Plus against a clinical standard: A brief report
title_fullStr Validating the OCS‐Plus against a clinical standard: A brief report
title_full_unstemmed Validating the OCS‐Plus against a clinical standard: A brief report
title_short Validating the OCS‐Plus against a clinical standard: A brief report
title_sort validating the ocs plus against a clinical standard a brief report
work_keys_str_mv AT robertsr validatingtheocsplusagainstaclinicalstandardabriefreport
AT vohorar validatingtheocsplusagainstaclinicalstandardabriefreport
AT webbss validatingtheocsplusagainstaclinicalstandardabriefreport
AT demeyeren validatingtheocsplusagainstaclinicalstandardabriefreport